Provided by Tiger Trade Technology Pte. Ltd.

AN2 Therapeutics, Inc.

3.77
-0.0600-1.57%
Post-market: 3.63-0.1400-3.71%19:54 EDT
Volume:451.92K
Turnover:1.64M
Market Cap:135.50M
PE:-3.24
High:3.82
Open:3.77
Low:3.44
Close:3.83
52wk High:6.91
52wk Low:1.00
Shares:35.94M
Float Shares:10.76M
Volume Ratio:1.07
T/O Rate:4.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1641
EPS(LYR):-1.1641
ROE:-52.14%
ROA:-30.93%
PB:2.55
PE(LYR):-3.24

Loading ...

AN2 Therapeutics Announces FDA Clearance to Proceed With 90-Patient Investigator-Initiated Trial (Iit) of Epetraborole in Patients With M. Abscessus Lung Disease

THOMSON REUTERS
·
Jan 12

AN2 Therapeutics Advances Chagas Disease and Oncology Programs and Reports Third Quarter 2025 Results

Reuters
·
Nov 13, 2025

AN2 Therapeutics Q3 net loss narrows to $9.4 mln

Reuters
·
Nov 13, 2025

Press Release: AN2 Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business and Scientific Highlights

Dow Jones
·
Nov 13, 2025

REFILE-BUZZ-U.S. STOCKS ON THE MOVE-Guardant Health, Tower Semiconductor, GlobalFoundries

Reuters
·
Nov 11, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Instacart, Plug Power, Crypto stocks

Reuters
·
Nov 10, 2025

AN2 Therapeutics, GSK Collaborate to Develop New Therapies for Tuberculosis

MT Newswires Live
·
Nov 10, 2025

Shares of AN2 Therapeutics up 1.8% After GSK Collaboration to Develop Tuberculosis Treatment

THOMSON REUTERS
·
Nov 10, 2025

BRIEF-AN2 Therapeutics Announces Research Collaboration With GSK

Reuters
·
Nov 10, 2025

AN2 Therapeutics Partners with GSK to Develop Boron-Based Tuberculosis Treatments

Reuters
·
Nov 10, 2025

AN2 Therapeutics Announces Research Collaboration With GSK to Advance Boron-Based Leurs-Inhibitors Targeting Tuberculosis (Tb)

THOMSON REUTERS
·
Nov 10, 2025

AN2 Therapeutics Inc. Officer Joshua M. Eizen Reports Disposal of Common Shares

Reuters
·
Nov 07, 2025

AN2 Therapeutics CEO to Join Fireside Chat at Evercore HealthCONx Conference

Reuters
·
Nov 07, 2025

AN2 Therapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview

Reuters
·
Nov 01, 2025

AN2 Therapeutics Gains 11%, Insider Trades Reap Benefit

Simply Wall St.
·
Oct 28, 2025